MedTrace Logo

Vitamin E Supplementation Effect in Management of Calcium Oxalate Crystals

NCT07715643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-07-20

No results posted yet for this study

Summary

Nephrolithiasis is a condition characterized by the formation of crystalline stones in the urinary system. The most common component of these stones is calcium oxalate. The current study was proposed to explore the effect of different concentration of vitamin E supplementation on Calcium oxalate crystal among nephrolithiatic patients.

Conditions

  • Nephrolithiasis
  • Calcium Oxalate Kidney Stones

Interventions

DRUG

Control Group T0

The participants were on conventional medicines

DIETARY_SUPPLEMENT

Intervention Group T1

T1 group participants were taking 200mg/day of Vitamin E supplementation once a day along with conventional medicines

DIETARY_SUPPLEMENT

Intervention Group T2

T2 group participants were taking 400mg/day of Vitamin E supplementation once a day along with conventional medicines

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-05
Primary Completion
2023-02-07
Completion
2023-04-05

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07715643 on ClinicalTrials.gov